Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-005769
Filing Date
2024-08-01
Accepted
2024-08-01 16:31:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4775
  Complete submission text file 0001950047-24-005769.txt   6322
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Subject) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 144 | Act: 33 | File No.: 001-39398 | Film No.: 241167266
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NURIX THERAPEUTICS, INC. 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address
van Houte Hans (Reporting) CIK: 0001817217 (see all company filings)

Type: 144